These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22842328)

  • 1. 17β-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement.
    McCoy SC; Yarrow JF; Conover CF; Borsa PA; Tillman MD; Conrad BP; Pingel JE; Wronski TJ; Johnson SE; Kristinsson HG; Ye F; Borst SE
    Bone; 2012 Oct; 51(4):667-73. PubMed ID: 22842328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate.
    Yarrow JF; Conover CF; McCoy SC; Lipinska JA; Santillana CA; Hance JM; Cannady DF; VanPelt TD; Sanchez J; Conrad BP; Pingel JE; Wronski TJ; Borst SE
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E650-60. PubMed ID: 21266670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of aromatase inhibition on the bone-protective effects of testosterone.
    Beck DT; Yarrow JF; Beggs LA; Otzel DM; Ye F; Conover CF; Miller JR; Balaez A; Combs SM; Leeper AM; Williams AA; Lachacz SA; Zheng N; Wronski TJ; Borst SE
    J Bone Miner Res; 2014 Nov; 29(11):2405-13. PubMed ID: 24764121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of visceral obesity and androgens on bone: trenbolone protects against loss of femoral bone mineral density and structural strength in viscerally obese and testosterone-deficient male rats.
    Donner DG; Elliott GE; Beck BR; Forwood MR; Du Toit EF
    Osteoporos Int; 2016 Mar; 27(3):1073-1082. PubMed ID: 26438310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and trenbolone enanthate increase mature myostatin protein expression despite increasing skeletal muscle hypertrophy and satellite cell number in rodent muscle.
    Dalbo VJ; Roberts MD; Mobley CB; Ballmann C; Kephart WC; Fox CD; Santucci VA; Conover CF; Beggs LA; Balaez A; Hoerr FJ; Yarrow JF; Borst SE; Beck DT
    Andrologia; 2017 Apr; 49(3):. PubMed ID: 27246614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of androgens on circulating adiponectin in male and female rodents.
    Yarrow JF; Beggs LA; Conover CF; McCoy SC; Beck DT; Borst SE
    PLoS One; 2012; 7(10):e47315. PubMed ID: 23071783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of myotrophic actions by testosterone and trenbolone on androgen-responsive muscle.
    Ye F; McCoy SC; Ross HH; Bernardo JA; Beharry AW; Senf SM; Judge AR; Beck DT; Conover CF; Cannady DF; Smith BK; Yarrow JF; Borst SE
    Steroids; 2014 Sep; 87():59-66. PubMed ID: 24928725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone dose dependently prevents bone and muscle loss in rodents after spinal cord injury.
    Yarrow JF; Conover CF; Beggs LA; Beck DT; Otzel DM; Balaez A; Combs SM; Miller JR; Ye F; Aguirre JI; Neuville KG; Williams AA; Conrad BP; Gregory CM; Wronski TJ; Bose PK; Borst SE
    J Neurotrauma; 2014 May; 31(9):834-45. PubMed ID: 24378197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat.
    Tezval M; Serferaz G; Rack T; Kolios L; Sehmisch S; Schmelz U; Tezval H; Stuermer KM; Stuermer EK
    World J Urol; 2011 Aug; 29(4):529-34. PubMed ID: 21298272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchiectomized rats.
    Prakasam G; Yeh JK; Chen MM; Castro-Magana M; Liang CT; Aloia JF
    Bone; 1999 May; 24(5):491-7. PubMed ID: 10321909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase.
    Borst SE; Conover CF; Carter CS; Gregory CM; Marzetti E; Leeuwenburgh C; Vandenborne K; Wronski TJ
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E507-14. PubMed ID: 17488806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat.
    Ke HZ; Qi H; Crawford DT; Chidsey-Frink KL; Simmons HA; Thompson DD
    Endocrinology; 2000 Apr; 141(4):1338-44. PubMed ID: 10746637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats.
    Yarrow JF; Conover CF; Purandare AV; Bhakta AM; Zheng N; Conrad B; Altman MK; Franz SE; Wronski TJ; Borst SE
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1213-22. PubMed ID: 18780767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
    Attardi BJ; Marck BT; Matsumoto AM; Koduri S; Hild SA
    J Androl; 2011; 32(2):183-92. PubMed ID: 20798389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome.
    Donner DG; Elliott GE; Beck BR; Bulmer AC; Lam AK; Headrick JP; Du Toit EF
    Endocrinology; 2016 Jan; 157(1):368-81. PubMed ID: 26584015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross talk between androgen and Wnt signaling potentially contributes to age-related skeletal muscle atrophy in rats.
    Mumford PW; Romero MA; Mao X; Mobley CB; Kephart WC; Haun CT; Roberson PA; Young KC; Martin JS; Yarrow JF; Beck DT; Roberts MD
    J Appl Physiol (1985); 2018 Aug; 125(2):486-494. PubMed ID: 29722624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Xu E; Yeh JK
    Chin J Physiol; 2008 Dec; 51(6):331-7. PubMed ID: 19280876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
    Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone histomorphometry of ovariectomized or orchiectomized rats fed a moderately magnesium-deficient fructose diet and treated with exogenous oestrogen or testosterone.
    Koh ET; Yeh JK; Bourdeau JE; Chen MM; Om AS
    Magnes Res; 1996 Mar; 9(1):13-21. PubMed ID: 8819090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats.
    Donner DG; Beck BR; Bulmer AC; Lam AK; Du Toit EF
    Steroids; 2015 Feb; 94():60-9. PubMed ID: 25554582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.